Skip to content

PHARMACIE G. DENEF: what changed

What changed

PHARMACIE G. DENEF

BE 0464.469.355
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€31,162
2023 · €126,463-€95,301
Equity
€404,848
2023 · €373,686+€31,162
Cash
€164,413
2023 · €85,333+€79,080
Balance sheet total
€1.5m
2023 · €1.3m+€259,625

Largest movements

2023 to 2024
Assets
  • Receivables within one year +€183,468

    up €183,468 (+32.5%), from €565,338 to €748,807

    of which Trade receivables: +€145,351

  • Cash +€79,080

    up €79,080 (+92.7%), from €85,333 to €164,413

    mainly Trade debts (+€235,605) and Depreciation (+€59,148)

  • Tangible fixed assets -€54,287

    down €54,287 (-13.4%), from €405,532 to €351,244

    of which Land and buildings: -€47,296

  • Stocks and contracts +€51,365

    up €51,365 (+25.9%), from €198,087 to €249,452

Equity and liabilities
  • Trade debts +€235,605

    up €235,605 (+47.8%), from €492,383 to €727,988

  • Debts after one year -€45,644

    down €45,644 (-20.7%), from €221,033 to €175,389

  • Profit (loss) carried forward +€31,162

    up €31,162 (+18.6%), from €167,379 to €198,541

  • Tax, wage and social debts +€25,532

    up €25,532 (+31.5%), from €81,110 to €106,642

    of which Taxes: +€16,000

Income statement
  • Gross operating margin -€91,063

    down €91,063 (-20.7%), from €438,917 to €347,854

  • Staff costs +€41,630

    up €41,630 (+21.8%), from €190,566 to €232,196

  • Taxes -€32,658

    down €32,658 (-71.5%), from €45,664 to €13,006

  • Depreciation -€5,422

    down €5,422 (-8.4%), from €64,570 to €59,148

Change in the result, 2023 to 2024

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2023 €126,463
Gross operating margin -€91,063
Staff costs -€41,630
Depreciation +€5,422
Other operating charges +€48
Financial income +€0
Financial charges -€736
Taxes +€32,658
Result 2024 €31,162
raises the resultlowers the result

Derived cash bridge

cash 2023 to 2024

The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€127,921
Investment -€4,861
Financing -€43,980
Cash 2023 €85,333
Net result for the year +€31,162
Depreciation +€59,148
Stocks and contracts -€51,365
Receivables within one year -€183,468
Trade debts +€235,605
Tax, wage and social debts +€25,532
Other debts +€11,306
Investment in fixed assets (net) -€4,861
Debts after one year -€45,644
Current portion of long-term debt +€1,664
Cash 2024 €164,413
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2023 2024 Change %
Total assets 20/58 €1,256,344 €1,515,969 +€259,625 +20.7%
Fixed assets 21/28 €407,585 €353,298 -€54,287 -13.3%
Tangible fixed assets 22/27 €405,532 €351,244 -€54,287 -13.4%
Land and buildings 22 €339,064 €291,768 -€47,296 -13.9%
Plant, machinery and equipment 23 €1,503 €4,238 +€2,735 +182%
Furniture and vehicles 24 €886 €760 -€126 -14.3%
Leasing and similar rights 25 €64,079 €54,479 -€9,600 -15.0%
Financial fixed assets 28 €2,054 €2,054 = 0.0%
Current assets 29/58 €848,759 €1,162,671 +€313,913 +37.0%
Stocks and contracts in progress 3 €198,087 €249,452 +€51,365 +25.9%
Stocks 30/36 €198,087 €249,452 +€51,365 +25.9%
Amounts receivable within one year 40/41 €565,338 €748,807 +€183,468 +32.5%
Trade receivables 40 €184,066 €329,418 +€145,351 +79.0%
Other amounts receivable 41 €381,272 €419,389 +€38,117 +10.0%
Cash at bank and in hand 54/58 €85,333 €164,413 +€79,080 +92.7%
Total equity and liabilities 10/49 €1,256,344 €1,515,969 +€259,625 +20.7%
Equity 10/15 €373,686 €404,848 +€31,162 +8.3%
Contributions 10/11 €141,000 €141,000 = 0.0%
Reserves 13 €65,307 €65,307 = 0.0%
Non-distributable reserves 130/1 €1,859 €1,859 = 0.0%
Reserves not available under the articles 1311 €1,859 €1,859 = 0.0%
Distributable reserves 133 €63,448 €63,448 = 0.0%
Profit (loss) carried forward 14 €167,379 €198,541 +€31,162 +18.6%
Amounts payable 17/49 €882,657 €1,111,121 +€228,464 +25.9%
Amounts payable after more than one year 17 €221,033 €175,389 -€45,644 -20.7%
Financial debts 170/4 €221,033 €175,389 -€45,644 -20.7%
Amounts payable within one year 42/48 €661,624 €935,732 +€274,108 +41.4%
Current portion of amounts payable after more than one year 42 €44,831 €46,495 +€1,664 +3.7%
Trade debts 44 €492,383 €727,988 +€235,605 +47.8%
Suppliers 440/4 €492,383 €727,988 +€235,605 +47.8%
Taxes, remuneration and social security 45 €81,110 €106,642 +€25,532 +31.5%
Taxes 450/3 €50,308 €66,308 +€16,000 +31.8%
Remuneration and social security 454/9 €30,802 €40,334 +€9,532 +30.9%
Other amounts payable 47/48 €43,300 €54,607 +€11,306 +26.1%
Remuneration, social security and pensions 62 €190,566 €232,196 +€41,630 +21.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €64,570 €59,148 -€5,422 -8.4%
Other operating charges 640/8 €892 €844 -€48 -5.4%
Gross operating margin 9900 €438,917 €347,854 -€91,063 -20.7%
Operating profit (loss) 9901 €182,888 €55,666 -€127,222 -69.6%
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €10,762 €11,498 +€736 +6.8%
Recurring financial charges 65 €10,762 €11,498 +€736 +6.8%
Profit (loss) for the period before taxes 9903 €172,127 €44,168 -€127,958 -74.3%
Income taxes 67/77 €45,664 €13,006 -€32,658 -71.5%
Profit (loss) for the period 9904 €126,463 €31,162 -€95,301 -75.4%
Profit (loss) for the period to be appropriated 9905 €126,463 €31,162 -€95,301 -75.4%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.